FDA proposes biosimilars approval pathway
Wednesday, February 15, 2012 - 09:10
in Health & Medicine
US biotechnology industry cautiously welcomes FDA’s draft guidance to facilitate biosimilars' development and approval
US biotechnology industry cautiously welcomes FDA’s draft guidance to facilitate biosimilars' development and approval